Abbott advances two pulsed field ablation studies for AFib treatment
Abbott has reached two milestones in a pair of trials evaluating the company’s pulsed field ablation (PFA) technology for the …
Abbott has reached two milestones in a pair of trials evaluating the company’s pulsed field ablation (PFA) technology for the …
Major medical device manufacturing company Medtronic has announced a US Food and Drugs Administration (FDA) class I recall of its …
Roche has gained the Conformité Européenne (CE) mark of approval for its VENTANA CLDN18 (43-14A) RxDx assay to identify patients …
Visionaries and industry leaders in medical design and manufacturing are heading to Minneapolis next week for the upcoming MD&M Midwest …
Illumina has launched a new benchtop next-generation sequencing (NGS) system designed to be more accessible for use in smaller labs. NGS …
Virginia-based Rivanna has initiated a feasibility study evaluating its artificial intelligence (AI) enabled Accuro XV musculoskeletal imaging system. The study will …
US company Inocras has announced the successful clinical validation of its CancerVision target enhanced whole genome sequencing (TE-WGS) technology. TE-WGS is …
Cytovale, a medical diagnostics company, has raised $100m in a Series D funding round led by Sands Capital for expediting …
Massachusetts-based blood pressure monitoring wearable company Dynocardia has announced that it has been the recipient of a National Institutes of …
Natus Medical has sought US Food and Drug Administration (FDA) clearance for its point-of-care EEG device. The company submitted a 510(k) …
The field of neurology has seen major leaps in the last decade, with new technology offering hope for people with …
Vy Spine has received clearance for its 3D printed LumiVy OsteoVy PEKK Lumbar IBF device from the US Food and …
A new type of self-adjusting neuromodulation is poised to transform the landscape of neurology, as per analyst reaction to results …
Johnson & Johnson (J&J) has announced the completion of its acquisition of V-Wave, a company specialising in the development of …
Diabetes software company Glooko has been able to secure $100m in funding to back the expansion of its platform that …